Ciolac, Dumitru; Gonzalez-Escamilla, Gabriel; Winter, Yaroslav et al.
Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammationNEURAL REGENERATION RESEARCH. Bd. 18. H. 8. 2023 S. 1717-1718
Moebus, Volker; Schmidt, Marcus
Breast Cancer Outome - What have we achievedBREAST CARE. 2023
Schraw, Jeremy M.; Petridou, Eleni Th.; Bonaventure, Audrey et al.
Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and Leukemia International ConsortiumCANCER CAUSES & CONTROL. 2023
Pawlowski, Johannes; Beczinski, Janina; Stege, Henner et al.
Bridging the gaps: management of lichen planus subtypes in a joint dermatology-oral surgery clinic<show/>CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2023
Kuhle, Stefan; Brown, Mary Margaret; Stanojevic, Sanja
Building a better model: abandon kitchen sink regressionARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION. 2023
Beutel, Till; Koestner, Clemens; Wild, Philipp S. et al.
Burnout, self-rated general health and life satisfaction among teachers and other academic occupational groupsFRONTIERS IN PUBLIC HEALTH. Bd. 11. 2023
Bartsch, Georg; Thomas, Christian; Tsaur, Igor et al.
Cabozantinib in patients with locally advanced or metastatic urothelial cell carcinoma who have progressed after cisplatin-based chemotherapy and anti-PD-1/PD-L1 therapy or after anti-PD-1/PD-L1 therapy only.JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. 2023
Vecsey-Nagy, M.; Varga-Szemes, A.; Emrich, T. et al.
Calcium scoring on coronary computed angiography tomography with photon-counting detector technology: Predictors of performanceJOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY. Bd. 17. H. 5. 2023 S. 328-335
Schultheis, Michael; Staubach-Renz, Petra; Grabbe, Stephan et al.
Can hidradenitis suppurativa patients classify their lesions by means of a digital lesion identification scheme?JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 21. H. 1. 2023 S. 27-32
Peisen, Felix; Gerken, Annika; Hering, Alessa et al.
Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register StudyDIAGNOSTICS. Bd. 13. H. 20. 2023